Fibromyalgia Root Causes: What the Research Actually Shows

Fibromyalgia is one of the most misunderstood, underfunded, and under-validated pain conditions in medicine. Patients are frequently told their pain is psychological, that nothing is structurally wrong, or that there's little to offer beyond pain management. Science tells a different story. The fibromyalgia root causes are increasingly well-characterised — involving measurable abnormalities in central pain processing, autonomic nervous system regulation, sleep architecture, gut microbiome composition, and neuroinflammatory signalling. This blog is written for people who want the actual science — clearly explained, without dismissal, and with real mechanistic detail.

Table of Contents

• 1. Fibromyalgia Root Causes: What the Research Actually Shows
• 2. What Fibromyalgia Is — And Why It Has Been So Difficult to Diagnose
• 3. Central Sensitisation — The Engine of Fibromyalgia Pain
• 4. HPA Axis Dysregulation — The Stress-Pain Connection in Fibromyalgia
• 5. Small Fibre Neuropathy — A New Understanding of Fibromyalgia Pain
• 6. Gut Microbiome and Fibromyalgia — The Emerging Connection
• 7. Sleep Architecture Disruption — Why Poor Sleep Doesn’t Just Cause Fatigue in Fibromyalgia
• 8. Frequently Asked Questions
• 9. Conclusion

Key Benefits

• What Fibromyalgia Is — And Why It Has Been So Difficult to Diagnose
• Fibromyalgia is classified as a centralised pain disorder — meaning the primary dysfunction lies in how the central nervous system processes pain signals, rather than in peripheral tissue damage. Standard investigations (MRI, blood tests, X-rays, nerve conduction studies) are typically normal — which historically led to misclassification as a psychological condition.
• Modern diagnostic criteria (2010/2016 ACR criteria) rely on the widespread pain index (WPI) and symptom severity scale (SSS), which assess pain distribution, fatigue, cognitive symptoms (fibro fog), and sleep quality. Crucially, no tender point count is required — reflecting the shift away from a purely musculoskeletal model.
• Key co-morbidities that should always be assessed alongside fibromyalgia: IBS (present in 30–70% of fibromyalgia patients), chronic fatigue syndrome/ME, anxiety and depression, headache disorders (migraine and tension-type), interstitial cystitis, and temporomandibular disorder. These overlaps are not coincidental — they reflect shared mechanisms.

Central Sensitisation — The Engine of Fibromyalgia Pain

Central sensitisation is the neurological process at the core of fibromyalgia root causes. It refers to a state of synaptic amplification in the spinal cord dorsal horn and brain that results in:

• Allodynia — pain from stimuli that would not normally be painful (light touch, moderate pressure, temperature changes)

• Hyperalgesia — exaggerated pain responses to stimuli that are mildly painful

• Temporal summation — repeated stimuli produce progressively escalating pain (the "wind-up" phenomenon)

• Widespread pain referral — pain signals are diffuse and poorly localised, spreading beyond the original site

The neurochemical basis of central sensitisation involves:

• Elevated glutamate and substance P in the cerebrospinal fluid (CSF) — documented in fibromyalgia patients vs controls

• Reduced GABA (inhibitory neurotransmitter) activity in the spinal cord

• Reduced descending inhibitory pain control (the brain's system for dampening incoming pain signals)

• Upregulation of NMDA (N-methyl-D-aspartate) glutamate receptors in the dorsal horn

• Neuroplastic changes in the somatosensory cortex

Neuroimaging studies using fMRI have documented abnormal brain activation patterns in fibromyalgia — specifically elevated activity in pain-processing regions (insula, anterior cingulate cortex, somatosensory cortex) in response to stimuli that produce minimal brain activation in healthy controls.

HPA Axis Dysregulation — The Stress-Pain Connection in Fibromyalgia Fibromyalgia and chronic stress have a well-documented bidirectional relationship. The majority of fibromyalgia patients report a significant stressful life event, trauma, or period of prolonged physical stress preceding the onset of symptoms — including viral illness, surgical recovery, major psychological trauma, or sustained physical overexertion. The mechanism: Chronic HPA axis activation from sustained stress produces a dysregulated cortisol rhythm. Rather than the normal diurnal pattern (high in the morning, falling through the day), fibromyalgia patients show a blunted cortisol awakening response and flattened diurnal cortisol curve — evidence of HPA hyporesponsiveness following prolonged activation. How HPA dysregulation drives fibromyalgia symptoms: • Blunted cortisol fails to provide its normal anti-inflammatory effects on the central nervous system • Persistent low-grade neuroinflammation develops • The autonomic nervous system shifts into chronic sympathetic dominance (impairs sleep, amplifies pain, worsens fatigue) • Growth hormone secretion (which occurs during deep sleep) is impaired, reducing muscle and tissue repair • The pain-inhibition systems of the periaqueductal grey matter are dysregulated

Small Fibre Neuropathy — A New Understanding of Fibromyalgia Pain One of the most significant recent findings in fibromyalgia research is the identification of small fibre neuropathy (SFN) in a substantial subset of patients — damage to the thin, unmyelinated C-fibres and lightly myelinated A-delta fibres that transmit pain and autonomic signals. Skin punch biopsy — a test that counts intraepidermal nerve fibre density — has shown reduced small nerve fibre density in 40–60% of fibromyalgia patients in multiple studies. These small fibres are responsible for pain, temperature sensation, and autonomic regulation of blood vessels. Their loss explains several fibromyalgia features: burning pain quality, autonomic dysfunction (heart rate variability changes, blood pressure dysregulation, temperature dysregulation), and the mismatch between pain severity and standard nerve conduction test findings (which only detect large fibre pathology).

Steps

1. Gut Microbiome and Fibromyalgia — The Emerging Connection
2. A 2019 study published in Pain (McGill University) was among the first to document a specific gut microbiome signature in fibromyalgia patients compared to healthy controls and people with other chronic pain conditions. The finding: fibromyalgia patients showed consistent and distinctive microbiome differences — reduced populations of Faecalibacterium prausnitzii (a key anti-inflammatory SCFA producer) and specific Prevotella species linked to pain regulation.
3. The gut-fibromyalgia connection operates through:
4. • Gut-brain axis signalling: dysbiotic gut bacteria produce altered metabolic byproducts that affect CNS neurotransmitter levels, particularly serotonin, GABA, and glutamate
5. • Neuroinflammation: gut-derived LPS crossing the blood-brain barrier activates microglia (the brain's immune cells) — contributing to neuroinflammation that sustains central sensitisation
6. • Serotonin regulation: 90% of serotonin is gut-produced; dysbiosis reduces serotonin availability, impairing descending pain inhibition
7. • Immune system: gut dysbiosis promotes Th1/Th17 immune dominance and elevated pro-inflammatory cytokines including IL-6 and IL-8, both elevated in fibromyalgia

Related Resources

• Sleep Architecture Disruption — Why Poor Sleep Doesn't Just Cause Fatigue in Fibromyalgia
• Sleep disruption in fibromyalgia is not merely a symptom — it is a driver of the core pathophysiology. A landmark finding by Harvey Moldofsky demonstrated that disrupting slow-wave (delta) sleep in healthy subjects produced fibromyalgia-like musculoskeletal pain and fatigue within days — pain that resolved when normal sleep was restored.
• In fibromyalgia, polysomnography (sleep study) consistently shows alpha-wave intrusion into slow-wave sleep — the brain is partially awake (alpha) during the stages that should be deepest sleep (delta). The consequences:
• • Growth hormone secretion (which peaks in slow-wave sleep) is severely impaired — reducing tissue repair, immune regulation, and anabolic recovery
• • The pain-inhibitory circuits that are normally restored during deep sleep remain dysfunctional
• • Cortisol regulation the following day is disrupted
• • Cognitive function (the "fibro fog") worsens proportionally to sleep quality
• Addressing sleep architecture — not just sleep duration — is one of the most high-yield interventions for fibromyalgia pain management, because it directly targets a root driver rather than a secondary symptom.

Frequently Asked Questions

The root causes of fibromyalgia are not a mystery. They represent a convergence of identifiable biological mechanisms — central sensitisation, dysregulated stress response, gut–brain axis disruption, neuroinflammation, and impaired sleep architecture — each reinforcing the others in a self-perpetuating cycle. This has important implications for recovery. Because each of these mechanisms is modifiable, fibromyalgia is not a fixed or irreversible state. Addressing gut health, regulating the stress response, restoring sleep architecture, and reducing neuroinflammation have all been shown to meaningfully impact pain severity, fatigue, and overall quality of life. The body is not permanently broken in fibromyalgia. The systems driving its symptoms are dysregulated — and dysregulated systems can be guided back toward balance when the right internal conditions are restored.